National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting, 44689 [2024-11074]

Download as PDF Federal Register / Vol. 89, No. 99 / Tuesday, May 21, 2024 / Notices 6021 Bethesda, MD 20892, (301) 496–9350, sheila.pirooznia@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Education Activities for Responsible Analyses of Complex, Large-Scale Data. Date: July 3, 2024. Time: 2:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Li Rebekah Feng, Ph.D., Scientific Review Officer, Division of Extramural Review, Scientific Review Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC, 6021 Bethesda, MD 20892, (301) 827–7245, rebekah.feng@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Targeting Inflammasomes in HIV and Substance Use. Date: July 8, 2024. Time: 10:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer, Division of Extramural Research, Scientific Review Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC, 6021 Bethesda, MD 20892, (301) 594–9460, Soyoun.cho@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: May 15, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–11068 Filed 5–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES ddrumheller on DSK120RN23PROD with NOTICES1 National Institutes of Health National Institute of Neurological Disorders and Stroke; Amended Notice of Meetings Notice is hereby given of a change in the meetings of the National Institute of Neurological Disorders and Stroke Special Emphasis Panel, VCID Center Without Walls, June 11, 2024, 10:00 a.m. to 6:00 p.m.; BRAIN Initiative Connectivity across Scales Data VerDate Sep<11>2014 18:13 May 20, 2024 Jkt 262001 Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed), June 13, 2024, 10:00 a.m. to 12:30 p.m.; and BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed), June 20, 2024, 10:00 a.m. to 6:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD, 20852 which were published in the Federal Register on May 15, 2024, FR Doc. 2024–10633, 89 FR 42479. This notice is being amended to change the meeting formats of all three meetings from in-person to virtual. The dates and times of these meetings will remain the same. The meetings are closed to the public. Dated: May 15, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–11075 Filed 5–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Neurological Disorders and Stroke Special Emphasis Panel, HEAL Initiative: Digital Biomarker, June 04, 2024, 10:00 a.m. to June 04, 2024, 06:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD, 20852 which was published in the Federal Register on May 13, 2024, FR Doc 2024–10379, 89 FR 41451. This notice is being amended to change the meeting format from inperson to virtual. The date and time will remain the same. The meeting is closed to the public. Dated: May 15, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–11074 Filed 5–20–24; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 44689 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Bioethics and Tech Development. Date: June 20, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Dem II, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20817 (Virtual Meeting). Contact Person: Debanjan Goswami, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Blvd., Suite 200, Bethesda, MD 20892, (301) 827–4614, debanjan.goswami@ nih.gov. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Career Development Awards (Ks) and Conference support (R13) Review. Date: June 25, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Dem II, Suite 920, 6707 Democracy Blvd., Bethesda, MD 20817 (Virtual Meeting). Contact Person: Alexander O Komendantov, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Blvd., Suite 959, Bethesda, MD 20892, (301) 496– 2763, alexander.komendantov@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health.) E:\FR\FM\21MYN1.SGM 21MYN1

Agencies

[Federal Register Volume 89, Number 99 (Tuesday, May 21, 2024)]
[Notices]
[Page 44689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11074]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Neurological Disorders and Stroke Special Emphasis Panel, 
HEAL Initiative: Digital Biomarker, June 04, 2024, 10:00 a.m. to June 
04, 2024, 06:00 p.m., National Institutes of Health, Neuroscience 
Center, 6001 Executive Boulevard, Rockville, MD, 20852 which was 
published in the Federal Register on May 13, 2024, FR Doc 2024-10379, 
89 FR 41451.
    This notice is being amended to change the meeting format from in-
person to virtual. The date and time will remain the same. The meeting 
is closed to the public.

    Dated: May 15, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-11074 Filed 5-20-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.